Repligen Corporation (RGEN) Presents at 7th Annual Wolfe Research Healthcare Conference Transcript
Douglas SchenkelWolfe Research, LLC All right. Good afternoon, everybody. I am Doug Schenkel with Wolfe Research. It’s my pleasure to welcome Jason Garland, Chief Financial Officer of Repligen; as well as Steven